The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1334
March 22, 2010
View Complete Issue         Table of Contents 2019 
A Morphine/Naltrexone Combination (Embeda) for Pain
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A Morphine/Naltrexone Combination (Embeda) for Pain
March 22, 2010 (Issue: 1334)
The FDA has approved an agonist/antagonist combination of morphine and naltrexone (Embeda – King) for treatment of chronic moderate to severe pain requiring around-the-clock analgesia for an extended period of time. The addition of naltrexone is...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: A Morphine/Naltrexone Combination (Embeda) for Pain
Article code: 1334b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.